Acetohexamide
(Redirected from Dimelor)
A sulfonylurea class antidiabetic drug
Acetohexamide is an oral hypoglycemic agent belonging to the sulfonylurea class of drugs. It is used in the management of type 2 diabetes mellitus to help control blood sugar levels. Acetohexamide works by stimulating the release of insulin from the beta cells of the pancreas.
Pharmacology[edit | edit source]
Acetohexamide is a first-generation sulfonylurea, which means it is one of the earlier drugs developed in this class. It functions by binding to the sulfonylurea receptor on the beta cells, leading to the closure of ATP-sensitive potassium channels. This action results in the depolarization of the cell membrane and the opening of voltage-gated calcium channels, which increases intracellular calcium and stimulates insulin secretion.
Chemical Structure[edit | edit source]
The chemical structure of acetohexamide is characterized by a sulfonylurea moiety, which is essential for its hypoglycemic activity. The presence of a cyclohexyl group differentiates it from other sulfonylureas and influences its pharmacokinetic properties.
Pharmacokinetics[edit | edit source]
Acetohexamide is absorbed from the gastrointestinal tract and undergoes hepatic metabolism. It is metabolized to an active metabolite, hydroxyhexamide, which also contributes to its hypoglycemic effect. The drug and its metabolites are excreted primarily in the urine.
Clinical Use[edit | edit source]
Acetohexamide is indicated for the treatment of type 2 diabetes in patients who cannot achieve adequate glycemic control with diet and exercise alone. It is typically used as part of a comprehensive diabetes management plan that includes lifestyle modifications.
Side Effects[edit | edit source]
Common side effects of acetohexamide include hypoglycemia, nausea, and dizziness. As with other sulfonylureas, there is a risk of severe hypoglycemia, especially in patients with renal or hepatic impairment, or those who are elderly.
Contraindications[edit | edit source]
Acetohexamide is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, and in those with known hypersensitivity to sulfonylureas. Caution is advised in patients with renal or hepatic impairment.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
